Merck Serono

Wednesday , September 15, 2010
13h00 – 14h30
Room 112 - Level 1

Lunch and drinks are courtesy of Merck Serono

ERBITUX setting new standards in head and neck cancer
Chairs :Jean Bourhis, France
             Ricard Mesía, Spain

13:00 – 13:05 Welcome and introduction
                       Ricard Mesía, Spain

13:05 – 13:25 Where are we now in the management of locally advanced SCCHN?
                       Kian Ang, US
13:25 – 13:45 New approaches for organ-preservation in locally advanced SCCHN
                       Andreas Dietz, Germany

13:45 – 14:00 Integrating Erbitux into clinical practice in LA SCCHN -A real world case study
                       Jürgen Debus, Germany

14:00 – 14:20 EXTREME - The first significant improvement in survival in R/M SCCHN for 30 years
                      Lisa Licitra, Italy

14:20 – 14:30 Discussion and closing remarks
                      Jean Bourhis, France